|
|
Volumn 7, Issue 12, 2008, Pages 967-
|
|
Market watch : Pharma industry strategic performance: 2007-2012E.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTIINFLAMMATORY AGENT;
ARIPIPRAZOLE;
BEVACIZUMAB;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
NEUROLEPTIC AGENT;
PIPERAZINE DERIVATIVE;
QUINOLONE DERIVATIVE;
COST;
DRUG CONTROL;
DRUG INDUSTRY;
DRUG THERAPY;
ECONOMICS;
FINANCIAL MANAGEMENT;
HUMAN;
NOTE;
REWARD;
STANDARD;
UNITED STATES;
ANGIOGENESIS INHIBITORS;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL;
ANTIPSYCHOTIC AGENTS;
COSTS AND COST ANALYSIS;
DRUG AND NARCOTIC CONTROL;
DRUG INDUSTRY;
DRUG THERAPY;
HUMANS;
MARKETING OF HEALTH SERVICES;
PIPERAZINES;
QUINOLONES;
REWARD;
UNITED STATES;
|
|
EID: 58149334911
PISSN: None
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd2768 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|
